Results 101 to 110 of about 34,432 (188)

K Banhatti Polynomials of Remdesivir, Chloroquine, Hydroxychloroquine: Research Advances for the Prevention and Treatment of COVID-19 [PDF]

, 2020
V R Kulli
openalex   +1 more source

Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase

, 2019
Ariane J. Brown, John J. Won, Rachel L. Graham, Kenneth H. Dinnon, Amy Sims, Joy Y. Feng, Tomáš Cihlář, Mark R. Denison, Ralph S. Baric, Timothy P. Sheahan   +9 more
openalex   +2 more sources

Intermolecular interaction among Remdesivir, RNA and RNA-dependent RNA polymerase of SARS-CoV-2 analyzed by fragment molecular orbital calculation

, 2020
Koichiro Kato, Teruki Honma, Kaori Fukuzawa   +2 more
openalex   +2 more sources

Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations

, 2020
Hoang Linh Nguyen, Nguyen Quoc Thai, Duc Toan Truong, Mai Suan Li   +3 more
openalex   +2 more sources

Remdesivir induced viral RNA and subgenomic RNA suppression, and evolution of viral variants in SARS-CoV-2 infected patients

, 2020
Florencia A. T. Boshier, Juanita Pang, Justin Penner, Joseph Hughes, Matthew Parker, James G. Shepherd, Nele Alders, Alasdair Bamford, Louis Grandjean, Stephanie Grünewald, James Hatcher, Timothy Best, Caroline Dalton, Patricia Dyal Bynoe, Claire Frauenfelder, Jutta Köeglmeier, Phoebe Myerson, Sunando Roy, Reneé Williams, Emma C. Thomson, Thushan I. de Silva, Richard A. Goldstein, Judith Breuer   +22 more
openalex   +1 more source

Remdesivir—Bringing Hope for COVID-19 Treatment [PDF]

, 2020
Naser F. Al‐Tannak, Ladislav Novotný, Adel Al‐Hunayan   +2 more
openalex   +1 more source

The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir

, 2020
Yan Zhao, Jing Sun, Yunfei Li, Zhengxuan Li, Yu Xie, Ruoqing Feng, Jincun Zhao, Yuhui Hu   +7 more
openalex   +1 more source

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven

Contemporary Clinical Trials Communications, 2020
From December 2019 to May 22, 2020 the emerging and ever-increasing pandemic of coronavirus 19 (COVID-19) had no effective and safe treatment. Not surprisingly, remdesivir attracted worldwide attention. In a trial published online ahead of print, of 1063
Richard D. Shih, Dennis G. Maki, Charles H. Hennekens   +2 more
doaj  

Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective [PDF]

, 2020
Zainab Gandhi, Zeeshan Mansuri, Snehal Bansod   +2 more
openalex   +1 more source

Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report

, 2020
Jennifer Jacobson, Kathleen M. Antony, Michael Beninati, William T. Alward, Kara K. Hoppe   +4 more
openalex   +1 more source